Jiangfeng Du

Shanxi Medical University

Papers

1

Total Citations

35

H-Index

1

About

Jiangfeng Du is a leading researcher at the forefront of nanomedicine and biomedical engineering, with a primary focus on the innovative application of liquid metal nanomaterials for cancer therapy. His most notable contribution is the pioneering development of transformable gallium-based liquid metal nanoparticles for tumor radiotherapy sensitization. In his landmark 2022 study, Du was the first to report the use of nanosized gallium-indium alloys to enhance the efficacy of radiotherapy, demonstrating how these unique, shape-shifting particles can improve tumor targeting and radiation absorption. This work, which has already garnered 35 citations, represents a significant breakthrough in the field, opening new avenues for more effective and less invasive cancer treatments. Du’s research uniquely bridges materials science and clinical oncology, showcasing the potential of room-temperature liquid metals beyond traditional applications in microfluidics and soft robotics. His innovative approach to designing responsive nanomaterials positions him as a rising authority in the development of next-generation theranostic agents for precision medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
35
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
Transformable Gallium‐Based Liquid Metal Nanoparticles for Tumor Radiotherapy Sensitization
35 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Shanxi Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago